- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03206606
Evaluation of a Mobile Application to Facilitate the Interpretation of Spirometry by Family Physicians and Residents
Evaluation of a Mobile Application to Facilitate the Interpretation of the Spirometry Test by Family Physicians and Family Medicine Residents: Impact on Prescription and Interpretation of This Test
Problematic: Spirometry is used to objectify the obstructive syndrome defining chronic obstructive pulmonary disease (COPD). However, this test remains underused in the primary care. The tools available for its interpretation are little used and the existence of several decision algorithms can create confusion during the diagnosis.
Principal objective: To evaluate the impact of a mobile application (SPIRO©) on medical practice (interpretation and prescription of spirometry) of family physicians and family medicine residents working in family medicine units (FMU) in Quebec affiliated with Laval University.
Secondary objective : To evaluate the usability of SPIRO© among family physicians and residents in family medicine working in FMU in Quebec affiliated with Laval University.
Methods: This is a pre-post clinical trial with control group. Participants (family MD and family medicine residents) will be recruited from the various FMU affiliated with Laval University. Participants working in the FMU in the experimental group will be able to use the SPIRO® mobile application to facilitate interpretation of the spirometry test results while participants in the control group will not have access to it during the study. The basic characteristics of the participants and various behavioral parameters based on the theory of planned behavior concerning the interpretation and prescription of spirometry test will be measured. Data from the control group will be collected before those in the experimental group at the time the application is not yet available, which will minimize contamination between groups. The data will be collected with questionnaires delivered in person to the participants before the intervention (T0 time) and then four months later (T1 time) during their team or research meeting. Participants will be recruited in eight of the 12 Quebec FMU affiliated with Laval University, who will be randomly assigned to two equal groups: control and experimental. The intervention will consist in sending the SPIRO© mobile application to participants in the experimental group who will use it for a period of four months.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Hypothesis : The investigators hypothesize that the use of the SPIRO© application will increase the skills and confidence of family physicians and family medicine residents in prescribing and interpreting spirometry compared to the control group.
The project will be conducted in the following six major steps: 1) Collection of socio-demographic and behavioral characteristics of participants using sections A, B, C and D of the NAPI questionnaire in the control group; 2) Intervention in the control group (they will continue their daily medical practice without being subject to any intervention by our research team), for a period of 4 months; 3) Measurement of behavioral changes in the control group using Sections B, C, D and E of the NAPI questionnaire 4 months after the start of the study; 4) Collection of socio-demographic and behavioral data from participants in the experimental group using sections A, B, C and D of the NAPI questionnaire; 5) E-mail distribution of the application and use of the application by participants in the experimental group for a period of four months, 6) Measurement of behavioral changes in the experimental group after the use of the application, Using sections B, C, D and E of the NAPI questionnaire as well as a questionnaire on the application SPIRO© (SPIRO questionnaire) which will evaluate the usability of this one.
The study has been approved by the research ethic board of the Health and Social Services Center of the old capital - attached to the Integrated Center for Health and Social Services of the National Capital.
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Quebec
-
Baie-Comeau, Quebec, Kanada, G4Z 3B8
- UMF de Manicouagan
-
Gaspé, Quebec, Kanada, G4X 2W2
- UMF de Gaspé
-
Lac-Etchemin, Quebec, Kanada, G0R 1S0
- UMF des Etchemins
-
Lévis, Quebec, Kanada, G6W 0J4
- UMF de Lévis
-
Quebec City, Quebec, Kanada, G1J 2G1
- Unité de médecine familiale - GMF Maizerets
-
Quebec City, Quebec, Kanada, G1L 3L5
- UMF Saint-François d'Assise
-
Quebec City, Quebec, Kanada, G1V 0B7
- Unité de médecine familiale Laval
-
Trois-Pistoles, Quebec, Kanada, G0L 4K0
- UMF de Trois-Pistoles
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- Participants need to be primary care physicians or residents in family medicine of 18 years old or more working in one of the 12 family medicine units in Quebec affiliated with Laval University.
Exclusion Criteria:
- Health professionals not practicing family medicine and residents of other specialties will not be eligible. Individuals who participated in the development of the " subjective Norms, Attitudes, Perceived behavioral control, Intentions (NAPI) " questionnaires (apparent validation) will be excluded.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Modele obserwacyjne: Kohorta
- Perspektywy czasowe: Spodziewany
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
Control Group
Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University.
|
|
|
Experimental Group
Primary care physicians and residents in family medicine of family medicine units affiliated with Laval University that will use the mobile application SPIRO(c) for a period of four months.
|
Participants in the Experimental Group will be asked to use SPIRO mobile application during a period of 4 months.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Beliefs about capabilities - interpretation
Ramy czasowe: six weeks
|
The beliefs about the capabilities of primary care physicians and residents in family medicine regarding interpretation of spirometry.
|
six weeks
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Beliefs about consequences - prescription
Ramy czasowe: six weeks
|
The beliefs about the consequences of primary care physicians and residents in family medicine regarding prescription of spirometry.
|
six weeks
|
|
Beliefs about consequences - interpretation
Ramy czasowe: six weeks
|
The beliefs about the consequences of primary care physicians and residents in family medicine regarding interpretation of spirometry.
|
six weeks
|
|
Beliefs about consequences - use of a mobile application
Ramy czasowe: six weeks
|
The beliefs about the consequences of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
|
six weeks
|
|
Moral norms - prescription
Ramy czasowe: six weeks
|
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding prescription of spirometry.
|
six weeks
|
|
Moral norms - interpretation
Ramy czasowe: six weeks
|
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding interpretation of spirometry.
|
six weeks
|
|
Moral norms - use of a mobile application
Ramy czasowe: six weeks
|
The beliefs about the moral norms of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
|
six weeks
|
|
Intentions - prescription
Ramy czasowe: six weeks
|
The beliefs about the intentions of primary care physicians and residents in family medicine regarding prescription of spirometry.
|
six weeks
|
|
Intentions - interpretation
Ramy czasowe: six weeks
|
The beliefs about the intentions of primary care physicians and residents in family medicine regarding interpretation of spirometry.
|
six weeks
|
|
Intentions - use of a mobile application
Ramy czasowe: six weeks
|
The beliefs about the intentions of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
|
six weeks
|
|
Social influence - prescription
Ramy czasowe: six weeks
|
The beliefs about the social influence of primary care physicians and residents in family medicine regarding prescription of spirometry.
|
six weeks
|
|
Social influence - interpretation
Ramy czasowe: six weeks
|
The beliefs about the social influence of primary care physicians and residents in family medicine regarding interpretation of spirometry.
|
six weeks
|
|
Social influence - use of a mobile application
Ramy czasowe: six weeks
|
The beliefs about the social influence of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
|
six weeks
|
|
Belief about capabilities - prescription
Ramy czasowe: six weeks
|
The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding prescription of spirometry.
|
six weeks
|
|
Belief about capabilities - use of a mobile application
Ramy czasowe: six weeks
|
The beliefs about the belief about capabilities of primary care physicians and residents in family medicine regarding the use of a mobile application to interpret spirometry.
|
six weeks
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Louis-Philippe Boulet, MD, Heart and Lung Institute
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Inne numery identyfikacyjne badania
- SPIRO-MD Residents
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na POChP
-
University Hospital, MahdiaNieznanyOstre zaostrzenie CopdTunezja
-
Centre Hospitalier Universitaire, AmiensZakończonyOstre zaostrzenie CopdFrancja
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaOspedale San Donato; Fondazione Salvatore Maugeri; Azienda Unita Sanitaria Locale... i inni współpracownicyRekrutacyjnyPOChP | Hiperkapnia | Zaostrzenie CopdWłochy
-
Texas A&M UniversityZakończonyObturacyjna choroba płuc | Zaostrzenie CopdStany Zjednoczone
-
National Taiwan University HospitalZakończony
-
Prince of Songkla UniversityZakończonyRozstrzenie oskrzeli | Zmniejszona czynność płuc | Zaostrzenie CopdTajlandia
-
Huashan HospitalNieznanyŻylna choroba zakrzepowo-zatorowa | Ostre zaostrzenie CopdChiny
-
Joon Young ChoiSeoul St. Mary's Hospital; Hallym University Medical Center; Konkuk University...ZakończonyPOChP | Zaostrzenie CopdRepublika Korei
-
University of Health Sciences LahoreJeszcze nie rekrutacja
Badania kliniczne na SPIRO
-
University of MichiganZakończonyMukowiscydozaStany Zjednoczone
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomAktywny, nie rekrutującyChoroby płucZjednoczone Królestwo
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomRekrutacyjny
-
China-Japan Friendship HospitalJeszcze nie rekrutacjaPrzewlekła obturacyjna choroba płuc
-
Massachusetts General HospitalJeszcze nie rekrutacjaLęk | Zaburzenia ze spektrum autyzmu
-
Memorial Sloan Kettering Cancer CenterRekrutacyjnyPozasutkowa choroba PagetaStany Zjednoczone
-
UpTru Inc.Jeszcze nie rekrutacjaZaburzenia związane z używaniem substancji (SUD)
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Jeszcze nie rekrutacjaPrzewlekłą chorobę nerekChiny
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)ZakończonyWycięcie tarczycy | Choroba tarczycy | Głowa i szyja | Zaburzenia głowy i szyi | Guz Warthina | Gruczolak pleomorficzny ślinianki przyusznejStany Zjednoczone
-
Keda LuRed Cross Hospital, Hangzhou, China; Shanghai 6th People's Hospital; The First... i inni współpracownicyJeszcze nie rekrutacjaNefropatia IgA (IgAN)